Author

L. Veronica Lee

Observed institution: Sanofi (United States)

OpenAlex ID: A5059482706

Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry

2019 · Corey K. Bradley, Tracy Y. Wang, et al. · Journal of the American Heart Association · 286

Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use

2018 · Michael G. Nanna, Ann Marie Navar, et al. · JAMA Cardiology · 122

PDF

Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry

2017 · Ann Marie Navar, Tracy Y. Wang, et al. · American Heart Journal · 94

Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

2018 · Michael G. Nanna, Ann Marie Navar, et al. · Journal of the American Heart Association · 82

PDF

Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials

2018 · Antonio J. Vallejo‐Vaz, Henry N. Ginsberg, et al. · Journal of the American Heart Association · 30

Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control

2019 · Antonio J. Vallejo-Vaz, Kausik K. Ray, et al. · Atherosclerosis · 28

PDF

Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry)

2019 · Angela Lowenstern, Ann Marie Navar, et al. · The American Journal of Cardiology · 23

Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry

2018 · Angela M. Lowenstern, Shuang Li, et al. · Journal of the American Heart Association · 21

PDF

Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry

2018 · Angela Lowenstern, Shuang Li, et al. · American Heart Journal · 19

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials

2017 · Alberico L. Catapano, L. Veronica Lee, et al. · Scientific Reports · 17

PDF

Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials

2018 · Dean J. Kereiakes, Norman E. Lepor, et al. · Atherosclerosis · 12

PDF

Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies

2019 · Frederick J. Raal, Jaakko Tuomilehto, et al. · Journal of clinical lipidology · 6

PDF

Abstract 17099: Additional LDL-C Reduction Achieved With Alirocumab Dose Increase on Background Statin

2015 · John J Kastelein, Dean J Kereiakes, et al. · Circulation · 3

Abstract 15219: Statin Decision-Making Since the 2013 AHA/ACC Cholesterol Guidelines: Do Clinicians Do What They Say?

2017 · Angela Lowenstern, Shuang Li, et al. · Circulation

TCT-586 Alirocumab efficacy and safety in patients with prior coronary revascularization

2017 · Dean Kereiakes, Norman Lepor, et al. · Journal of the American College of Cardiology

PDF

Predictive factors for alirocumab dose increase in patients with heterozygous familial hypercholesterolaemia

2017 · Antonio J. Vallejo-Vaz, Eli M. Roth, et al. · Atherosclerosis

Abstract 17106: Impact of Communication Format and Risk Horizon on Patient Perceptions of CVD Risk: Findings From the PALM Registry

2016 · Ann Marie Návar, Tracy Y Wang, et al. · Circulation

Abstract 118: Are Patients with Atherosclerotic Cardiovascular Disease Receiving Appropriate Lipid Management? Insights from the PALM Registry

2016 · Ann M Navar, Eric D Peterson, et al. · Circulation Cardiovascular Quality and Outcomes

Abstract 17279: Have the 2013 AHA/ACC Cholesterol Guidelines Affected Clinicians’ Lipid Management Strategies?

2015 · Ann M Navar, Anne C Goldberg, et al. · Circulation

Works count: 19

Citation count: 743

H-index: 11

I10-index: 11